However, while our understanding and targeting of the specific oncogenic alterations driving lung cancer has progressed significantly, considerably less is known about the tumor suppressive landscape of LUAD outside of the limited number of well-characterized tumor suppressors such as RB, TP53, P16, and LKB1. This evidence concerns the gene TP53 and lung carcinoma.